Cell Analysis Instruments
Cell Analysis Instruments market is segmented by Type and by Application. Players, stakeholders, ... Read More
Global Celiac Drugs Market Insights and Forecast to 2031
1 Study Coverage
1.1 Celiac Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Celiac Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 First Line Of Treatment
1.2.3 Second Line Of Treatment
1.3 Market by Application
1.3.1 Global Celiac Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Men
1.3.3 Women
1.3.4 Children
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Celiac Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Celiac Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Celiac Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Celiac Drugs Sales by Region
2.4.1 Global Celiac Drugs Sales by Region (2017-2022)
2.4.2 Global Sales Celiac Drugs by Region (2023-2028)
2.5 Global Celiac Drugs Revenue by Region
2.5.1 Global Celiac Drugs Revenue by Region (2017-2022)
2.5.2 Global Celiac Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Celiac Drugs Sales by Manufacturers
3.1.1 Global Top Celiac Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global Celiac Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Celiac Drugs in 2021
3.2 Global Celiac Drugs Revenue by Manufacturers
3.2.1 Global Celiac Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global Celiac Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Celiac Drugs Revenue in 2021
3.3 Global Celiac Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Celiac Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Celiac Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Celiac Drugs Sales by Type
4.1.1 Global Celiac Drugs Historical Sales by Type (2017-2022)
4.1.2 Global Celiac Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global Celiac Drugs Sales Market Share by Type (2017-2028)
4.2 Global Celiac Drugs Revenue by Type
4.2.1 Global Celiac Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global Celiac Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global Celiac Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Celiac Drugs Price by Type
4.3.1 Global Celiac Drugs Price by Type (2017-2022)
4.3.2 Global Celiac Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Celiac Drugs Sales by Application
5.1.1 Global Celiac Drugs Historical Sales by Application (2017-2022)
5.1.2 Global Celiac Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global Celiac Drugs Sales Market Share by Application (2017-2028)
5.2 Global Celiac Drugs Revenue by Application
5.2.1 Global Celiac Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global Celiac Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global Celiac Drugs Revenue Market Share by Application (2017-2028)
5.3 Global Celiac Drugs Price by Application
5.3.1 Global Celiac Drugs Price by Application (2017-2022)
5.3.2 Global Celiac Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America Celiac Drugs Market Size by Type
6.1.1 North America Celiac Drugs Sales by Type (2017-2028)
6.1.2 North America Celiac Drugs Revenue by Type (2017-2028)
6.2 North America Celiac Drugs Market Size by Application
6.2.1 North America Celiac Drugs Sales by Application (2017-2028)
6.2.2 North America Celiac Drugs Revenue by Application (2017-2028)
6.3 North America Celiac Drugs Market Size by Country
6.3.1 North America Celiac Drugs Sales by Country (2017-2028)
6.3.2 North America Celiac Drugs Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Celiac Drugs Market Size by Type
7.1.1 Europe Celiac Drugs Sales by Type (2017-2028)
7.1.2 Europe Celiac Drugs Revenue by Type (2017-2028)
7.2 Europe Celiac Drugs Market Size by Application
7.2.1 Europe Celiac Drugs Sales by Application (2017-2028)
7.2.2 Europe Celiac Drugs Revenue by Application (2017-2028)
7.3 Europe Celiac Drugs Market Size by Country
7.3.1 Europe Celiac Drugs Sales by Country (2017-2028)
7.3.2 Europe Celiac Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Celiac Drugs Market Size by Type
8.1.1 Asia Pacific Celiac Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific Celiac Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Celiac Drugs Market Size by Application
8.2.1 Asia Pacific Celiac Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific Celiac Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific Celiac Drugs Market Size by Region
8.3.1 Asia Pacific Celiac Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific Celiac Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Celiac Drugs Market Size by Type
9.1.1 Latin America Celiac Drugs Sales by Type (2017-2028)
9.1.2 Latin America Celiac Drugs Revenue by Type (2017-2028)
9.2 Latin America Celiac Drugs Market Size by Application
9.2.1 Latin America Celiac Drugs Sales by Application (2017-2028)
9.2.2 Latin America Celiac Drugs Revenue by Application (2017-2028)
9.3 Latin America Celiac Drugs Market Size by Country
9.3.1 Latin America Celiac Drugs Sales by Country (2017-2028)
9.3.2 Latin America Celiac Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Celiac Drugs Market Size by Type
10.1.1 Middle East and Africa Celiac Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa Celiac Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Celiac Drugs Market Size by Application
10.2.1 Middle East and Africa Celiac Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa Celiac Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa Celiac Drugs Market Size by Country
10.3.1 Middle East and Africa Celiac Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa Celiac Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 ADMA Biologics
11.1.1 ADMA Biologics Corporation Information
11.1.2 ADMA Biologics Overview
11.1.3 ADMA Biologics Celiac Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 ADMA Biologics Celiac Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 ADMA Biologics Recent Developments
11.2 Amgen
11.2.1 Amgen Corporation Information
11.2.2 Amgen Overview
11.2.3 Amgen Celiac Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Amgen Celiac Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Amgen Recent Developments
11.3 Anthera Pharmaceuticals
11.3.1 Anthera Pharmaceuticals Corporation Information
11.3.2 Anthera Pharmaceuticals Overview
11.3.3 Anthera Pharmaceuticals Celiac Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Anthera Pharmaceuticals Celiac Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Anthera Pharmaceuticals Recent Developments
11.4 Bayer
11.4.1 Bayer Corporation Information
11.4.2 Bayer Overview
11.4.3 Bayer Celiac Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Bayer Celiac Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Bayer Recent Developments
11.5 Biogen
11.5.1 Biogen Corporation Information
11.5.2 Biogen Overview
11.5.3 Biogen Celiac Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Biogen Celiac Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Biogen Recent Developments
11.6 BioLineRx
11.6.1 BioLineRx Corporation Information
11.6.2 BioLineRx Overview
11.6.3 BioLineRx Celiac Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 BioLineRx Celiac Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 BioLineRx Recent Developments
11.7 Biotest
11.7.1 Biotest Corporation Information
11.7.2 Biotest Overview
11.7.3 Biotest Celiac Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Biotest Celiac Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Biotest Recent Developments
11.8 Bristol-Myers Squibb
11.8.1 Bristol-Myers Squibb Corporation Information
11.8.2 Bristol-Myers Squibb Overview
11.8.3 Bristol-Myers Squibb Celiac Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Bristol-Myers Squibb Celiac Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Bristol-Myers Squibb Recent Developments
11.9 Celgene
11.9.1 Celgene Corporation Information
11.9.2 Celgene Overview
11.9.3 Celgene Celiac Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Celgene Celiac Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Celgene Recent Developments
11.10 Celimmune
11.10.1 Celimmune Corporation Information
11.10.2 Celimmune Overview
11.10.3 Celimmune Celiac Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Celimmune Celiac Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Celimmune Recent Developments
11.11 F Hoffmann-La Roche
11.11.1 F Hoffmann-La Roche Corporation Information
11.11.2 F Hoffmann-La Roche Overview
11.11.3 F Hoffmann-La Roche Celiac Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 F Hoffmann-La Roche Celiac Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 F Hoffmann-La Roche Recent Developments
11.12 ImmunogenX
11.12.1 ImmunogenX Corporation Information
11.12.2 ImmunogenX Overview
11.12.3 ImmunogenX Celiac Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 ImmunogenX Celiac Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 ImmunogenX Recent Developments
11.13 Immunomedics
11.13.1 Immunomedics Corporation Information
11.13.2 Immunomedics Overview
11.13.3 Immunomedics Celiac Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Immunomedics Celiac Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Immunomedics Recent Developments
11.14 ImmusanT
11.14.1 ImmusanT Corporation Information
11.14.2 ImmusanT Overview
11.14.3 ImmusanT Celiac Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 ImmusanT Celiac Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 ImmusanT Recent Developments
11.15 Innovate Biopharmaceuticals
11.15.1 Innovate Biopharmaceuticals Corporation Information
11.15.2 Innovate Biopharmaceuticals Overview
11.15.3 Innovate Biopharmaceuticals Celiac Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Innovate Biopharmaceuticals Celiac Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Innovate Biopharmaceuticals Recent Developments
11.16 Johnson & Johnson
11.16.1 Johnson & Johnson Corporation Information
11.16.2 Johnson & Johnson Overview
11.16.3 Johnson & Johnson Celiac Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Johnson & Johnson Celiac Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Johnson & Johnson Recent Developments
11.17 Kedrion Biopharma
11.17.1 Kedrion Biopharma Corporation Information
11.17.2 Kedrion Biopharma Overview
11.17.3 Kedrion Biopharma Celiac Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Kedrion Biopharma Celiac Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Kedrion Biopharma Recent Developments
11.18 LFB Group
11.18.1 LFB Group Corporation Information
11.18.2 LFB Group Overview
11.18.3 LFB Group Celiac Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 LFB Group Celiac Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 LFB Group Recent Developments
11.19 Merck
11.19.1 Merck Corporation Information
11.19.2 Merck Overview
11.19.3 Merck Celiac Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.19.4 Merck Celiac Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Merck Recent Developments
11.20 Novartis
11.20.1 Novartis Corporation Information
11.20.2 Novartis Overview
11.20.3 Novartis Celiac Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.20.4 Novartis Celiac Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 Novartis Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Celiac Drugs Industry Chain Analysis
12.2 Celiac Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Celiac Drugs Production Mode & Process
12.4 Celiac Drugs Sales and Marketing
12.4.1 Celiac Drugs Sales Channels
12.4.2 Celiac Drugs Distributors
12.5 Celiac Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Celiac Drugs Industry Trends
13.2 Celiac Drugs Market Drivers
13.3 Celiac Drugs Market Challenges
13.4 Celiac Drugs Market Restraints
14 Key Findings in The Global Celiac Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Celiac Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of First Line Of Treatment
Table 3. Major Manufacturers of Second Line Of Treatment
Table 4. Global Celiac Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Celiac Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Celiac Drugs Sales by Region (2017-2022) & (K MT)
Table 7. Global Celiac Drugs Sales Market Share by Region (2017-2022)
Table 8. Global Celiac Drugs Sales by Region (2023-2028) & (K MT)
Table 9. Global Celiac Drugs Sales Market Share by Region (2023-2028)
Table 10. Global Celiac Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Celiac Drugs Revenue Market Share by Region (2017-2022)
Table 12. Global Celiac Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Celiac Drugs Revenue Market Share by Region (2023-2028)
Table 14. Global Celiac Drugs Sales by Manufacturers (2017-2022) & (K MT)
Table 15. Global Celiac Drugs Sales Share by Manufacturers (2017-2022)
Table 16. Global Celiac Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Celiac Drugs Revenue Share by Manufacturers (2017-2022)
Table 18. Celiac Drugs Price by Manufacturers (2017-2022) &(USD/MT)
Table 19. Global Celiac Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Celiac Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Celiac Drugs as of 2021)
Table 21. Celiac Drugs Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Celiac Drugs Product Offered
Table 23. Date of Manufacturers Enter into Celiac Drugs Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Celiac Drugs Sales by Type (2017-2022) & (K MT)
Table 26. Global Celiac Drugs Sales by Type (2023-2028) & (K MT)
Table 27. Global Celiac Drugs Sales Share by Type (2017-2022)
Table 28. Global Celiac Drugs Sales Share by Type (2023-2028)
Table 29. Global Celiac Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Celiac Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Celiac Drugs Revenue Share by Type (2017-2022)
Table 32. Global Celiac Drugs Revenue Share by Type (2023-2028)
Table 33. Celiac Drugs Price by Type (2017-2022) & (USD/MT)
Table 34. Global Celiac Drugs Price Forecast by Type (2023-2028) & (USD/MT)
Table 35. Global Celiac Drugs Sales by Application (2017-2022) & (K MT)
Table 36. Global Celiac Drugs Sales by Application (2023-2028) & (K MT)
Table 37. Global Celiac Drugs Sales Share by Application (2017-2022)
Table 38. Global Celiac Drugs Sales Share by Application (2023-2028)
Table 39. Global Celiac Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Celiac Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Celiac Drugs Revenue Share by Application (2017-2022)
Table 42. Global Celiac Drugs Revenue Share by Application (2023-2028)
Table 43. Celiac Drugs Price by Application (2017-2022) & (USD/MT)
Table 44. Global Celiac Drugs Price Forecast by Application (2023-2028) & (USD/MT)
Table 45. North America Celiac Drugs Sales by Type (2017-2022) & (K MT)
Table 46. North America Celiac Drugs Sales by Type (2023-2028) & (K MT)
Table 47. North America Celiac Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Celiac Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Celiac Drugs Sales by Application (2017-2022) & (K MT)
Table 50. North America Celiac Drugs Sales by Application (2023-2028) & (K MT)
Table 51. North America Celiac Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Celiac Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Celiac Drugs Sales by Country (2017-2022) & (K MT)
Table 54. North America Celiac Drugs Sales by Country (2023-2028) & (K MT)
Table 55. North America Celiac Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Celiac Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Celiac Drugs Sales by Type (2017-2022) & (K MT)
Table 58. Europe Celiac Drugs Sales by Type (2023-2028) & (K MT)
Table 59. Europe Celiac Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Celiac Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Celiac Drugs Sales by Application (2017-2022) & (K MT)
Table 62. Europe Celiac Drugs Sales by Application (2023-2028) & (K MT)
Table 63. Europe Celiac Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Celiac Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Celiac Drugs Sales by Country (2017-2022) & (K MT)
Table 66. Europe Celiac Drugs Sales by Country (2023-2028) & (K MT)
Table 67. Europe Celiac Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Celiac Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Celiac Drugs Sales by Type (2017-2022) & (K MT)
Table 70. Asia Pacific Celiac Drugs Sales by Type (2023-2028) & (K MT)
Table 71. Asia Pacific Celiac Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Celiac Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Celiac Drugs Sales by Application (2017-2022) & (K MT)
Table 74. Asia Pacific Celiac Drugs Sales by Application (2023-2028) & (K MT)
Table 75. Asia Pacific Celiac Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Celiac Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Celiac Drugs Sales by Region (2017-2022) & (K MT)
Table 78. Asia Pacific Celiac Drugs Sales by Region (2023-2028) & (K MT)
Table 79. Asia Pacific Celiac Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Celiac Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Celiac Drugs Sales by Type (2017-2022) & (K MT)
Table 82. Latin America Celiac Drugs Sales by Type (2023-2028) & (K MT)
Table 83. Latin America Celiac Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Celiac Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Celiac Drugs Sales by Application (2017-2022) & (K MT)
Table 86. Latin America Celiac Drugs Sales by Application (2023-2028) & (K MT)
Table 87. Latin America Celiac Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Celiac Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Celiac Drugs Sales by Country (2017-2022) & (K MT)
Table 90. Latin America Celiac Drugs Sales by Country (2023-2028) & (K MT)
Table 91. Latin America Celiac Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Celiac Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Celiac Drugs Sales by Type (2017-2022) & (K MT)
Table 94. Middle East and Africa Celiac Drugs Sales by Type (2023-2028) & (K MT)
Table 95. Middle East and Africa Celiac Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Celiac Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Celiac Drugs Sales by Application (2017-2022) & (K MT)
Table 98. Middle East and Africa Celiac Drugs Sales by Application (2023-2028) & (K MT)
Table 99. Middle East and Africa Celiac Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Celiac Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Celiac Drugs Sales by Country (2017-2022) & (K MT)
Table 102. Middle East and Africa Celiac Drugs Sales by Country (2023-2028) & (K MT)
Table 103. Middle East and Africa Celiac Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Celiac Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 105. ADMA Biologics Corporation Information
Table 106. ADMA Biologics Description and Major Businesses
Table 107. ADMA Biologics Celiac Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 108. ADMA Biologics Celiac Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. ADMA Biologics Recent Developments
Table 110. Amgen Corporation Information
Table 111. Amgen Description and Major Businesses
Table 112. Amgen Celiac Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 113. Amgen Celiac Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Amgen Recent Developments
Table 115. Anthera Pharmaceuticals Corporation Information
Table 116. Anthera Pharmaceuticals Description and Major Businesses
Table 117. Anthera Pharmaceuticals Celiac Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 118. Anthera Pharmaceuticals Celiac Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Anthera Pharmaceuticals Recent Developments
Table 120. Bayer Corporation Information
Table 121. Bayer Description and Major Businesses
Table 122. Bayer Celiac Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 123. Bayer Celiac Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Bayer Recent Developments
Table 125. Biogen Corporation Information
Table 126. Biogen Description and Major Businesses
Table 127. Biogen Celiac Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 128. Biogen Celiac Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Biogen Recent Developments
Table 130. BioLineRx Corporation Information
Table 131. BioLineRx Description and Major Businesses
Table 132. BioLineRx Celiac Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 133. BioLineRx Celiac Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. BioLineRx Recent Developments
Table 135. Biotest Corporation Information
Table 136. Biotest Description and Major Businesses
Table 137. Biotest Celiac Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 138. Biotest Celiac Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Biotest Recent Developments
Table 140. Bristol-Myers Squibb Corporation Information
Table 141. Bristol-Myers Squibb Description and Major Businesses
Table 142. Bristol-Myers Squibb Celiac Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 143. Bristol-Myers Squibb Celiac Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Bristol-Myers Squibb Recent Developments
Table 145. Celgene Corporation Information
Table 146. Celgene Description and Major Businesses
Table 147. Celgene Celiac Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 148. Celgene Celiac Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Celgene Recent Developments
Table 150. Celimmune Corporation Information
Table 151. Celimmune Description and Major Businesses
Table 152. Celimmune Celiac Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 153. Celimmune Celiac Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Celimmune Recent Developments
Table 155. F Hoffmann-La Roche Corporation Information
Table 156. F Hoffmann-La Roche Description and Major Businesses
Table 157. F Hoffmann-La Roche Celiac Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 158. F Hoffmann-La Roche Celiac Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. F Hoffmann-La Roche Recent Developments
Table 160. ImmunogenX Corporation Information
Table 161. ImmunogenX Description and Major Businesses
Table 162. ImmunogenX Celiac Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 163. ImmunogenX Celiac Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 164. ImmunogenX Recent Developments
Table 165. Immunomedics Corporation Information
Table 166. Immunomedics Description and Major Businesses
Table 167. Immunomedics Celiac Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 168. Immunomedics Celiac Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 169. Immunomedics Recent Developments
Table 170. ImmusanT Corporation Information
Table 171. ImmusanT Description and Major Businesses
Table 172. ImmusanT Celiac Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 173. ImmusanT Celiac Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 174. ImmusanT Recent Developments
Table 175. Innovate Biopharmaceuticals Corporation Information
Table 176. Innovate Biopharmaceuticals Description and Major Businesses
Table 177. Innovate Biopharmaceuticals Celiac Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 178. Innovate Biopharmaceuticals Celiac Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 179. Innovate Biopharmaceuticals Recent Developments
Table 180. Johnson & Johnson Corporation Information
Table 181. Johnson & Johnson Description and Major Businesses
Table 182. Johnson & Johnson Celiac Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 183. Johnson & Johnson Celiac Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 184. Johnson & Johnson Recent Developments
Table 185. Kedrion Biopharma Corporation Information
Table 186. Kedrion Biopharma Description and Major Businesses
Table 187. Kedrion Biopharma Celiac Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 188. Kedrion Biopharma Celiac Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 189. Kedrion Biopharma Recent Developments
Table 190. LFB Group Corporation Information
Table 191. LFB Group Description and Major Businesses
Table 192. LFB Group Celiac Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 193. LFB Group Celiac Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 194. LFB Group Recent Developments
Table 195. Merck Corporation Information
Table 196. Merck Description and Major Businesses
Table 197. Merck Celiac Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 198. Merck Celiac Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 199. Merck Recent Developments
Table 200. Novartis Corporation Information
Table 201. Novartis Description and Major Businesses
Table 202. Novartis Celiac Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 203. Novartis Celiac Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 204. Novartis Recent Developments
Table 205. Key Raw Materials Lists
Table 206. Raw Materials Key Suppliers Lists
Table 207. Celiac Drugs Distributors List
Table 208. Celiac Drugs Customers List
Table 209. Celiac Drugs Market Trends
Table 210. Celiac Drugs Market Drivers
Table 211. Celiac Drugs Market Challenges
Table 212. Celiac Drugs Market Restraints
Table 213. Research Programs/Design for This Report
Table 214. Key Data Information from Secondary Sources
Table 215. Key Data Information from Primary Sources
List of Figures
Figure 1. Celiac Drugs Product Picture
Figure 3. Global Celiac Drugs Market Share by Type in 2021 & 2028
Figure 3. First Line Of Treatment Product Picture
Figure 4. Second Line Of Treatment Product Picture
Figure 5. Global Celiac Drugs Market Share by Application in 2021 & 2028
Figure 6. Men
Figure 7. Women
Figure 8. Children
Figure 9. Celiac Drugs Report Years Considered
Figure 10. Global Celiac Drugs Sales 2017-2028 (K MT)
Figure 11. Global Celiac Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Celiac Drugs Revenue 2017-2028 (US$ Million)
Figure 13. Global Celiac Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 14. Global Celiac Drugs Sales Market Share by Region (2017-2022)
Figure 15. Global Celiac Drugs Sales Market Share by Region (2023-2028)
Figure 16. North America Celiac Drugs Sales YoY (2017-2028) & (K MT)
Figure 17. North America Celiac Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 18. Europe Celiac Drugs Sales YoY (2017-2028) & (K MT)
Figure 19. Europe Celiac Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Asia-Pacific Celiac Drugs Sales YoY (2017-2028) & (K MT)
Figure 21. Asia-Pacific Celiac Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Latin America Celiac Drugs Sales YoY (2017-2028) & (K MT)
Figure 23. Latin America Celiac Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Middle East & Africa Celiac Drugs Sales YoY (2017-2028) & (K MT)
Figure 25. Middle East & Africa Celiac Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 26. The Celiac Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 27. The Top 5 and 10 Largest Manufacturers of Celiac Drugs in the World: Market Share by Celiac Drugs Revenue in 2021
Figure 28. Global Celiac Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 29. Global Celiac Drugs Sales Market Share by Type (2017-2028)
Figure 30. Global Celiac Drugs Revenue Market Share by Type (2017-2028)
Figure 31. Global Celiac Drugs Sales Market Share by Application (2017-2028)
Figure 32. Global Celiac Drugs Revenue Market Share by Application (2017-2028)
Figure 33. North America Celiac Drugs Sales Market Share by Type (2017-2028)
Figure 34. North America Celiac Drugs Revenue Market Share by Type (2017-2028)
Figure 35. North America Celiac Drugs Sales Market Share by Application (2017-2028)
Figure 36. North America Celiac Drugs Revenue Market Share by Application (2017-2028)
Figure 37. North America Celiac Drugs Sales Share by Country (2017-2028)
Figure 38. North America Celiac Drugs Revenue Share by Country (2017-2028)
Figure 39. U.S. Celiac Drugs Revenue (2017-2028) & (US$ Million)
Figure 40. Canada Celiac Drugs Revenue (2017-2028) & (US$ Million)
Figure 41. Europe Celiac Drugs Sales Market Share by Type (2017-2028)
Figure 42. Europe Celiac Drugs Revenue Market Share by Type (2017-2028)
Figure 43. Europe Celiac Drugs Sales Market Share by Application (2017-2028)
Figure 44. Europe Celiac Drugs Revenue Market Share by Application (2017-2028)
Figure 45. Europe Celiac Drugs Sales Share by Country (2017-2028)
Figure 46. Europe Celiac Drugs Revenue Share by Country (2017-2028)
Figure 47. Germany Celiac Drugs Revenue (2017-2028) & (US$ Million)
Figure 48. France Celiac Drugs Revenue (2017-2028) & (US$ Million)
Figure 49. U.K. Celiac Drugs Revenue (2017-2028) & (US$ Million)
Figure 50. Italy Celiac Drugs Revenue (2017-2028) & (US$ Million)
Figure 51. Russia Celiac Drugs Revenue (2017-2028) & (US$ Million)
Figure 52. Asia Pacific Celiac Drugs Sales Market Share by Type (2017-2028)
Figure 53. Asia Pacific Celiac Drugs Revenue Market Share by Type (2017-2028)
Figure 54. Asia Pacific Celiac Drugs Sales Market Share by Application (2017-2028)
Figure 55. Asia Pacific Celiac Drugs Revenue Market Share by Application (2017-2028)
Figure 56. Asia Pacific Celiac Drugs Sales Share by Region (2017-2028)
Figure 57. Asia Pacific Celiac Drugs Revenue Share by Region (2017-2028)
Figure 58. China Celiac Drugs Revenue (2017-2028) & (US$ Million)
Figure 59. Japan Celiac Drugs Revenue (2017-2028) & (US$ Million)
Figure 60. South Korea Celiac Drugs Revenue (2017-2028) & (US$ Million)
Figure 61. India Celiac Drugs Revenue (2017-2028) & (US$ Million)
Figure 62. Australia Celiac Drugs Revenue (2017-2028) & (US$ Million)
Figure 63. Taiwan Celiac Drugs Revenue (2017-2028) & (US$ Million)
Figure 64. Indonesia Celiac Drugs Revenue (2017-2028) & (US$ Million)
Figure 65. Thailand Celiac Drugs Revenue (2017-2028) & (US$ Million)
Figure 66. Malaysia Celiac Drugs Revenue (2017-2028) & (US$ Million)
Figure 67. Philippines Celiac Drugs Revenue (2017-2028) & (US$ Million)
Figure 68. Latin America Celiac Drugs Sales Market Share by Type (2017-2028)
Figure 69. Latin America Celiac Drugs Revenue Market Share by Type (2017-2028)
Figure 70. Latin America Celiac Drugs Sales Market Share by Application (2017-2028)
Figure 71. Latin America Celiac Drugs Revenue Market Share by Application (2017-2028)
Figure 72. Latin America Celiac Drugs Sales Share by Country (2017-2028)
Figure 73. Latin America Celiac Drugs Revenue Share by Country (2017-2028)
Figure 74. Mexico Celiac Drugs Revenue (2017-2028) & (US$ Million)
Figure 75. Brazil Celiac Drugs Revenue (2017-2028) & (US$ Million)
Figure 76. Argentina Celiac Drugs Revenue (2017-2028) & (US$ Million)
Figure 77. Middle East and Africa Celiac Drugs Sales Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Celiac Drugs Revenue Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Celiac Drugs Sales Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Celiac Drugs Revenue Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Celiac Drugs Sales Share by Country (2017-2028)
Figure 82. Middle East and Africa Celiac Drugs Revenue Share by Country (2017-2028)
Figure 83. Turkey Celiac Drugs Revenue (2017-2028) & (US$ Million)
Figure 84. Saudi Arabia Celiac Drugs Revenue (2017-2028) & (US$ Million)
Figure 85. U.A.E Celiac Drugs Revenue (2017-2028) & (US$ Million)
Figure 86. Celiac Drugs Value Chain
Figure 87. Celiac Drugs Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
ADMA Biologics Amgen Anthera Pharmaceuticals Bayer Biogen BioLineRx Biotest Bristol-Myers Squibb Celgene Celimmune F Hoffmann-La Roche ImmunogenX Immunomedics ImmusanT Innovate Biopharmaceuticals Johnson & Johnson Kedrion Biopharma LFB Group Merck Novartis